Exo Releases FDA-Cleared AI Apps for Heart and Lung Diagnosis
Medical imaging software company Exo announces the availability of its U.S. FDA-cleared cardiac and lung AI applications on Exo Iris, its handheld ultrasound device.
Medical imaging software company Exo announces the availability of its U.S. FDA-cleared cardiac and lung AI applications on Exo Iris, its handheld ultrasound device.
Researchers have developed a pH-responsive sticker for ultrasound monitoring, enabling early detection of anastomotic leaks post-surgery, with potential to revolutionize patient monitoring.
Philips announces that it has received U.S. FDA 510(k) clearance for its X11-4t Mini 3D TEE transducer, which enhances the early diagnosis of structural heart disease through detailed cardiac imaging.
Siemens Healthineers has introduced the Acuson Maple, an AI-powered ultrasound system designed for rapid diagnosis and assessment in various clinical settings, offering versatility, portability, and enhanced efficiency, with applications in emerging markets, small hospitals, outpatient centers, private practices, and urgent care facilities.
Read MoreGE HealthCare has integrated AI-driven Caption Guidance technology into its Venue Family point-of-care ultrasound systems, facilitating real-time guidance for capturing high-quality cardiac images.
Read MoreGE HealthCare has secured a more than $44 million grant from the Bill & Melinda Gates Foundation to develop artificial intelligence-assisted ultrasound assessment tools.
Read MoreNew physician guidelines now recommend use of contrast-enhanced ultrasound to diagnose hepatocellular carcinoma, the most common primary liver cancer.
Read MoreUsing ultrasound technology in a focused way might lead to notable changes in how the brain works, possibly leading to treatments for issues like depression, addiction, or anxiety, according to a recent study.
Read More